Terminalia arjuna in coronary artery disease: Ethnopharmacology, pre-clinical, clinical & safety evaluation
- 1 September 2014
- journal article
- review article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 155 (2) , 1029-1045
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Activity-guided isolation of antioxidants from the leaves ofTerminalia arjunaNatural Product Research, 2013
- Lifetime Risks of Cardiovascular DiseaseNew England Journal of Medicine, 2012
- Two new bioactive oleanane triterpene glycosides from Terminalia arjuna Natural Product Research, 2008
- Heart Disease and Stroke Statistics—2008 UpdateCirculation, 2008
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Phenolic contents and antioxidant activity of some food and medicinal plantsInternational Journal of Food Sciences and Nutrition, 2005
- Terminoside A, a new triterpene glycoside from the bark ofTerminalia arjunainhibits nitric oxide production in murine macrophagesJournal of Asian Natural Products Research, 2003
- Salutary effect of Terminalia Arjuna in patients with severe refractory heart failureInternational Journal of Cardiology, 1995
- Structure of terminic acid, a dihydroxytriterpene carboxylic acid from Terminalia arjuna☆Phytochemistry, 1983
- Chemical examination of the roots of Terminalia arjuna—the structures of arjunoside III and arjunoside IV, two new triterpenoid glycosidesPhytochemistry, 1982